Oxcarbazepine (GP 47.680): A Possible Alternative to Carbamazepine?

Epilepsia

Volumn 28, Issue 6, 1987, Pages 693-698

  Houtkooper, M A ^a   Lammertsma, A ^a   Meyer, J W A ^a   Goedhart, D M ^a   Meinardi, H ^a   van Oorschot, C A E H ^b   Blom, G F ^b   Hoppener R J E A ^c   Hulsman, J A R J ^c  

^a Nstituut Voor Epilepsiebestrijding ^*  (Netherlands)

^b Hans Berger Kliniek   (Netherlands)

^c NONE   (Netherlands)

Author keywords

Anticonvulsants; Carbamazepine; Controlled clinical trials; Drug evaluation; Epilepsy; GP47.680; Oxcarbazepine; Seizure

Indexed keywords

CARBAMAZEPINE; OXCARBAZEPINE;

CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; EPILEPSY; HUMAN; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; VERTIGO;

ADOLESCENT; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMAN; MALE; MIDDLE AGE; RANDOM ALLOCATION; SEIZURES; TIME FACTORS;

EID: 0342358734     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1987.tb03702.x     Document Type: Article

References (8)

1. Oxcarbazepine in patients hypersensitive to carbamazepine
2. Pharmacokinetics and metabolism of GP 47 779, the main human metabolite of oxcarbazepine (GP 47 680) in animals and healthy volunteers
3. Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)
4. Possible hazard of valpromide‐carbamazepine combination therapy in epilepsy
5. Clinical trial for the estimation of anticonvulsive properties and side reactions of a new drug keto‐carbamazepine
6. Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers